Does NINTEDANIB ESYLATE Cause Idiopathic pulmonary fibrosis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Idiopathic pulmonary fibrosis have been filed in association with NINTEDANIB ESYLATE (Ofev). This represents 9.4% of all adverse event reports for NINTEDANIB ESYLATE.
11
Reports of Idiopathic pulmonary fibrosis with NINTEDANIB ESYLATE
9.4%
of all NINTEDANIB ESYLATE reports
5
Deaths
1
Hospitalizations
How Dangerous Is Idiopathic pulmonary fibrosis From NINTEDANIB ESYLATE?
Of the 11 reports, 5 (45.5%) resulted in death, 1 (9.1%) required hospitalization, and 5 (45.5%) were considered life-threatening.
Is Idiopathic pulmonary fibrosis Listed in the Official Label?
Yes, Idiopathic pulmonary fibrosis is listed as a known adverse reaction in the official FDA drug label for NINTEDANIB ESYLATE.
What Other Side Effects Does NINTEDANIB ESYLATE Cause?
Diarrhoea (54)
Nausea (24)
Decreased appetite (20)
Fatigue (20)
Vomiting (20)
Dyspnoea (18)
Weight decreased (17)
Off label use (16)
Constipation (13)
Dizziness (13)
What Other Drugs Cause Idiopathic pulmonary fibrosis?
NINTEDANIB (1,905)
PIRFENIDONE (413)
TAMSULOSIN (103)
TREPROSTINIL (84)
SIMVASTATIN (79)
METFORMIN (39)
MACITENTAN (34)
METHOTREXATE (33)
ADALIMUMAB (32)
AMBRISENTAN (31)
Which NINTEDANIB ESYLATE Alternatives Have Lower Idiopathic pulmonary fibrosis Risk?
NINTEDANIB ESYLATE vs NIRAPARIB
NINTEDANIB ESYLATE vs NIRMATRELVIR\RITONAVIR
NINTEDANIB ESYLATE vs NIROGACESTAT
NINTEDANIB ESYLATE vs NIROGACESTAT HYDROBROMIDE
NINTEDANIB ESYLATE vs NIRSEVIMAB